Holen Sie sich die Stockscreener-App
2.11
3.43%
0.07
Handel nachbörslich:
2.10
-0.010
-0.47%
Finanzdaten der Immuneering Corp-Aktie (IMRX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
5.99%
15.33
|
16.30 | 13.93 | 13.50 | 14.68 |
| Operating Income/Loss |
5.99%
-15.33
|
-16.30 | -13.93 | -13.50 | -14.68 |
| Income/Loss From Continuing Operations Before Tax |
5.14%
-14.31
|
-15.08 | -12.60 | -12.19 | -13.60 |
| Income/Loss From Continuing Operations After Tax |
5.14%
-14.31
|
-15.08 | -12.60 | -12.19 | -13.60 |
|
Net Income/Loss
|
5.14%
-14.31
|
-15.08 | -12.60 | -12.19 | -13.60 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
10,114%
29.37
|
0.2876 | 29.27 | 28.65 | 26.44 |
| Diluted Average Shares |
10,114%
29.37
|
0.2876 | 29.27 | 28.65 | 26.44 |
| Basic Earnings Per Share |
5.77%
-0.49
|
-0.52 | -0.43 | -0.43 | -0.51 |
| Diluted Earnings Per Share |
5.77%
-0.49
|
-0.52 | -0.43 | -0.43 | -0.51 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.93%
3.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):